<H1>Chapter DOI: 10.1208/aapsj070490<br/>Cited-By Count: 3</H1><table border="1" width="30%"><tr><td>Total References</td><td>37</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>36</td></tr><tr><td>BibStructured Count</td><td width="10%">37</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>23</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Itier V, Bertrand D. Neuronal nicotinic receptors: from protein structure to function.<Emphasis Type="Italic">FEBS Lett.</Emphasis> 2001;504:118&#8211;125.</td><td><a href=http://dx.doi.org/10.1016/S0014-5793(01)02702-8>10.1016/S0014-5793(01)02702-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Whiting P, Lindstrom J. Pharmacological properties of immunoisolated neuronal nicotinic receptors.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1986;6:3061&#8211;3069.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Whiting P, Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1987;84:595&#8211;599.</td><td><a href=http://dx.doi.org/10.1073/pnas.84.2.595>10.1073/pnas.84.2.595</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1992;41:31&#8211;37.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Picciotto MR, Zoli M, Lena C, et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain.<Emphasis Type="Italic">Nature.</Emphasis> 1995;374:65&#8211;67.</td><td><a href=http://dx.doi.org/10.1038/374065a0>10.1038/374065a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Zoli M, Lena C, Picciotto MR, Changeux J-P. Identification of 4 classes of brain nicotinic receptors using beta2 mutant mice.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1998;18:4461&#8211;4472.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Marks MJ, Stitzel JA, Grady SR, Picciotto MR, Changeux JP, Collins AC. Nicotinic-agonist stimulated<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and [<Superscript>3</Superscript>H]epibatidine binding of mice differing in &#946;2 genotype.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2000;39:2632&#8211;2645.</td><td><a href=http://dx.doi.org/10.1016/S0028-3908(00)00115-5>10.1016/S0028-3908(00)00115-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC. Characterization of [(125)I]epibatidine binding and nicotinic agonist-mediated (86)Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2002;81:1102&#8211;1115.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2002.00910.x>10.1046/j.1471-4159.2002.00910.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Marks MJ, Farnham DA, Grady SR, Collins AC. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1993;264:542&#8211;552.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Marks MJ, Whiteaker P, Calcaterra J, et al. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;289:1090&#8211;1103.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Nguyen HN, Rasmussen BA, Perry DC. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;90:40&#8211;49.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.2004.02482.x>10.1111/j.1471-4159.2004.02482.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Eaton JB, Peng JH, Schroeder KM, et al. Characterization of human &#945;4&#946;2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;64:1283&#8211;1294.</td><td><a href=http://dx.doi.org/10.1124/mol.64.6.1283>10.1124/mol.64.6.1283</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Karadsheh MS, Shah MS, Tang X, Macdonald RL, Stitzel JA. Functional characterization of mouse &#945;4&#946;2 nicotinic acetylcholine receptors stably expressed in HEK293T cells.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;91:1138&#8211;1150.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.2004.02801.x>10.1111/j.1471-4159.2004.02801.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Decker MW, Anderson DJ, Brioni JD, et al. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1995;280:79&#8211;89.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(95)00191-M>10.1016/0014-2999(95)00191-M</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Puttfarcken PS, Manelli AM, Arneric SP, Donnelly-Roberts DL. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1997;69:930&#8211;938.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1997.69030930.x>10.1046/j.1471-4159.1997.69030930.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, FirstPage, Author_FamilyName_1, Author_FamilyName_2, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J, Kellar KJ. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1998;54:322&#8211;333.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ. Dextromethorphan and its metabolite dextrorphan block &#945;3&#946;4 neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;293:962&#8211;967.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibChapter</td><td>Lukas R, Fryer J, Eaton J, Gentry C. Some methods for studies of nicotinic acetylcholine receptor pharmacology. In: Levin ED, ed.<Emphasis Type="Italic">Nicotinic Receptors and the Nervous System</Emphasis>. Boca Raton, FL: CRC Press, 2002:3&#8211;27.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1201/9781420038521>10.1201/9781420038521</a></td><td><b>CrossRef-Meta</b></td>
<td>PublisherName</td><td>CrossRef</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Crooks PA, Ravard A, Wilkins LH, Teng L-H, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine release by pyridine<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist.<Emphasis Type="Italic">Drug Dev Res.</Emphasis> 1995;36:91&#8211;102.</td><td><a href=http://dx.doi.org/10.1002/ddr.430360204>10.1002/ddr.430360204</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Dwoskin LP, Xu R, Ayers JT, Crooks PA. Recent developments in neuronal nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Curr Opin Ther Patents.</Emphasis> 2000;10:1561&#8211;1581.</td><td><a href=http://dx.doi.org/10.1517/13543776.10.10.1561>10.1517/13543776.10.10.1561</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Dwoskin LP, Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2001;298:395&#8211;402.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Wilkins LH, Haubner A, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S-(-)-nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;301:1088&#8211;1096.</td><td><a href=http://dx.doi.org/10.1124/jpet.301.3.1088>10.1124/jpet.301.3.1088</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Wilkins LH, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with &#945;4&#946;2<Superscript>*</Superscript> and &#945;7<Superscript>*</Superscript> neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;304:400&#8211;410.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.043349>10.1124/jpet.102.043349</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Xu R, Dwoskin LP, Grinevich V, Sumithran SP, Crooks PA. Synthesis and evaluation of conformationally restricted pyridine<Emphasis Type="Italic">N</Emphasis>-alkylated nicotine analogs as nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Drug Dev Res.</Emphasis> 2002;55:173&#8211;186.</td><td><a href=http://dx.doi.org/10.1002/ddr.10049>10.1002/ddr.10049</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Allen DD, Lockman PR, Roder KE, Dwoskin LP, Crooks PA. Active transport of high affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;304:1268&#8211;1274.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.045856>10.1124/jpet.102.045856</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Crooks PA, Ayers JT, Xu R, et al. Development of subtype selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2004;14:1869&#8211;1874.</td><td><a href=http://dx.doi.org/10.1016/j.bmcl.2003.10.074>10.1016/j.bmcl.2003.10.074</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Marks MJ, Robinson SF, Collins AC. Nicotinic agonists differ in activation and desensitization of<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from mouse thalamic synaptosomes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1996;277:1383&#8211;1396.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels.<Emphasis Type="Italic">Nature</Emphasis>. 1996;380:347&#8211;351.</td><td><a href=http://dx.doi.org/10.1038/380347a0>10.1038/380347a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Goldman D, Deneris E, Luyten W, Kochhar A, Patrick J, Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system.<Emphasis Type="Italic">Cell.</Emphasis> 1987;48:965&#8211;973.</td><td><a href=http://dx.doi.org/10.1016/0092-8674(87)90705-7>10.1016/0092-8674(87)90705-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Yu ZJ, Morgan DG, Wecker L. Distribution of 3 nicotinic receptor alpha 4 mRNA transcripts in rat brain: selective regulation by nicotine administration.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1996;66:1326&#8211;1329.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Stitzel JA, Dobelis P, Jimenez M, Collins AC. Long sleep and short sleep mice differ in nicotine-stimulated<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and &#945;4 nicotinic receptor subunit cDNA sequence.<Emphasis Type="Italic">Pharmacogenetics</Emphasis>. 2001;11:331&#8211;339.</td><td><a href=http://dx.doi.org/10.1097/00008571-200106000-00008>10.1097/00008571-200106000-00008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. A polymorphism in the mouse neuronal &#945;4 nicotinic receptor subunit results in an alteration in receptor function.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2002;62:334&#8211;342.</td><td><a href=http://dx.doi.org/10.1124/mol.62.2.334>10.1124/mol.62.2.334</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of &#945;4&#946;2 nicotinic acetylcholine receptor expressed in<Emphasis Type="Italic">Xenopus laevis</Emphasis> oocytes.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1998;54:1124&#8211;1131.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Liu C, Nordberg A, Zhang X. Differential co-expression of nicotinic acetylcholine receptor alpha 4 and beta 2 subunit genes in various regions of rat brain.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1996;7:1645&#8211;1649.</td><td><a href=http://dx.doi.org/10.1097/00001756-199607080-00024>10.1097/00001756-199607080-00024</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Katz B, Thesleff S. A study of the &#8220;desensitization&#8221; produced by acetylcholine at the motor end-plate.<Emphasis Type="Italic">J Physiol.</Emphasis> 1957;138:63&#8211;80.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Edelstein SJ, Schaad O, Henry E, Bertrand D, Changeux JP. A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions.<Emphasis Type="Italic">Biol Cybern.</Emphasis> 1996;75:361&#8211;379.</td><td><a href=http://dx.doi.org/10.1007/s004220050302>10.1007/s004220050302</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Karlin A. Emerging structure of the nicotinic acetylcholine receptors.<Emphasis Type="Italic">Nat Rev Neurosci.</Emphasis> 2002;3:102&#8211;114.</td><td><a href=http://dx.doi.org/10.1038/nrn731>10.1038/nrn731</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>